Rizwan Shaikh, MD
Ophthalmology · New Orleans, LANPI 1154736791
Payments from drug & device makers
Across 51 payments — averaging $82.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$1K
- Alimera Sciences, Inc.$794
- Bausch & Lomb, A Division Of Bausch Health US, LLC$356
- Genentech USA, Inc.$317
- Regeneron Healthcare Solutions, Inc.$277
- NEW World Medical,inc.$251
- plus $926 from 10 others
What the payments were for
- Speaking & faculty fees$3508%
- Travel & lodging$62315%
- Food & beverage$3,24077%
- Education$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 9 | $1,305 |
| Alimera Sciences, Inc. | 5 | $794 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 5 | $356 |
| Genentech USA, Inc. | 8 | $317 |
| Regeneron Healthcare Solutions, Inc. | 7 | $277 |
| NEW World Medical,inc. | 2 | $251 |
| AbbVie | 2 | $226 |
| Genentech, Inc. | 1 | $139 |
| Spark Therapeutics, Inc. | 1 | $115 |
| Glaukos Corporation | 1 | $105 |
| Sight Sciences, Inc. | 1 | $97 |
| Apellis Pharmaceuticals, Inc. | 4 | $96 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $65 |
| Bausch & Lomb Americas Inc. | 2 | $37 |
| Ocular Therapeutix, Inc. | 1 | $32 |
| Biogen | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Iluvien$709
- DAILIES$306
- SUSVIMO$286
- VABYSMO$286
- Ahmed Glaucoma Valve$161
- Kahook Dual Blade$161
- Constellation$147
- Lucentis$147
- Centurion$142
- EYLEA$125
- OZURDEX$125
- LUXTURNA$115
- STELLARIS$109
- CRYSTALENS$109
- ENVISTA$109
- STELLARIS PC$105
- TRULIGN TORIC$105
- TORIC$105
- AKREOS MICS$105
- iStent inject Trabecular Micro-Bypass Stent System$105
How this compares
$4,226 in reported general payments places this provider in the 70th percentile of 286 ophthalmology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 229 | $6,681 |
| IlevroNepafenac | 12 | $4,795 |
| Difluprednate | 22 | $1,918 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 81 | $1,355 |
| Ketorolac Tromethamine | 57 | $1,100 |
| Latanoprost | 66 | $864 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 71 | $621 |
| Brimonidine Tartrate | 54 | $546 |
| Timolol Maleate | 23 | $295 |
| Dorzolamide Hcl | 18 | $275 |
| Ofloxacin | 22 | $236 |
| ErythromycinErythromycin Base | 11 | $120 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in New Orleans
- Delmar CaldwellNew Orleans$282K
- Ze ZhangNew Orleans$103K
- Rebecca MetzingerNew Orleans$63K
- Peter KastlNew Orleans$32K
- Benjamin LeeNew Orleans$7K
- Glen CangelosiNew Orleans$6K
- Matthew BoltonNew Orleans$5K
- Blake WilliamsonBaton Rouge$482K
- William ReadMonroe$303K
- Ruben GrigorianWest Monroe$192K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.